Raymond O. Huggenberger is Independent Director of Inogen, Inc. Mr. Huggenberger previously served as our Chief Executive Officer from 2008 until March 1, 2017 and as our President from 2008 until January 1, 2016. Prior to joining our company, Mr. Huggenberger held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, including: Vice President of Marketing for Sunrise’s German subsidiary from 1994 to 1996, President of Sunrise’s German division from 1998 until 2000, President of the European Operating Group from 2000 to 2002, President and Chief Operating Officer from 2002 until 2004, and President of European Operations 2006 to 2007. Mr. Huggenberger also held a consultant position with McDermott and Bull Inc., an executive search firm, from 2005 to 2006 and the position of Managing Director in the healthcare division of TA Triumph Adler AG, a document process management firm, from 1996 to 1998. Mr. Huggenberger currently serves on the Board of Directors of Tactile Systems Technology Inc., a publicly traded company, Clarify Medical Inc., Ebb Therapeutics, and Sommetrics, Inc., which are all medical device companies, as well as Intricon Corporation, a medical technology company. Mr. Huggenberger graduated from AKAD University in Rendsburg, Germany in Economics and completed the Advanced Marketing Strategies Program at INSEAD, Fontainebleau, France. The Board believes that he is qualified to serve as a director of Inogen because of his deep understanding of our business, operations and strategy and extensive executive and director roles with healthcare companies.
What is Raymond Huggenberger's net worth?
The estimated net worth of Raymond Huggenberger is at least $247,059.15 as of July 15th, 2021. Mr. Huggenberger owns 24,583 shares of Inogen stock worth more than $247,059 as of November 16th. This net worth estimate does not reflect any other investments that Mr. Huggenberger may own. Learn More about Raymond Huggenberger's net worth.
How do I contact Raymond Huggenberger?
Has Raymond Huggenberger been buying or selling shares of Inogen?
Raymond Huggenberger has not been actively trading shares of Inogen over the course of the past ninety days. Most recently, Raymond Huggenberger sold 6,594 shares of the business's stock in a transaction on Monday, August 16th. The shares were sold at an average price of $62.69, for a transaction totalling $413,377.86. Learn More on Raymond Huggenberger's trading history.
Who are Inogen's active insiders?
Are insiders buying or selling shares of Inogen?
In the last year, insiders at the medical technology company sold shares 1 times. They sold a total of 10,000 shares worth more than $85,600.00. The most recent insider tranaction occured on May, 10th when EVP Jason Somer sold 10,000 shares worth more than $85,600.00. Insiders at Inogen own 1.0% of the company.
Learn More about insider trades at Inogen. Information on this page was last updated on 5/10/2024.